DNA Brands, Inc. (DNAX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -421.26 Thousand | -434.49 Thousand | -1.09 Million | -34.06 Thousand | -7.52 | -107.59 Thousand |
| Net Income | -374.92 Thousand | -303.92 Thousand | -1.24 Million | -180.62 Thousand | -461.97 | -314.87 Thousand |
| Depreciation & Amortization | - | 3532.00 | 3863.00 | 5060.00 | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -46.34 Thousand | -134.1 Thousand | 146.14 Thousand | 141.5 Thousand | 454.45 | 207.28 Thousand |
| Other non-cash items | - | 7064.00 | 7727.00 | 10.12 Thousand | - | - |
| Investing Cash Flow | - | - | 1 Million | -27.6 Thousand | - | - |
| Investments in PPE | - | - | - | -27.6 Thousand | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 1 Million | - | - | - |
| Other Investing Activities | - | - | 1000.00 | - | - | - |
| Financing Cash Flow | 356.29 Thousand | 486.6 Thousand | 109.4 Thousand | - | - | 115 Thousand |
| Debt repayment | -356.29 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 486.6 Thousand | 109.4 Thousand | - | - | 115 Thousand |
| Other Financing Activities | - | - | 109.40 | - | - | 115.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -46.34 Thousand | -134.1 Thousand | 146.14 Thousand | 141.5 Thousand | 454.45 | 207.28 Thousand |
| Cash at beginning of period | 66.68 Thousand | 14.57 Thousand | 641.00 | 62.3 Thousand | 69.82 | 62.41 Thousand |
| Cash at end of period | 1708.00 | 66.68 Thousand | 14.57 Thousand | 641.00 | 62.30 | 69.81 Thousand |
| Capital Expenditure | - | - | - | -27.6 Thousand | - | - |
| Effect of forex changes on cash | - | - | -13.92 Thousand | - | - | - |
| Net cash flow / Change in cash | -64.97 Thousand | 52.1 Thousand | 13.93 Thousand | -61.66 Thousand | -7.52 | 7405.00 |
| Free Cash Flow | -421.26 Thousand | -434.49 Thousand | -1.09 Million | -61.66 Thousand | -7.52 | -107.59 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -569.6 Thousand | 55.69 Thousand | -73.25 Thousand | -374.92 Thousand | -112.25 Thousand | -69.05 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 573.93 Thousand | -55.64 Thousand | 75.09 Thousand | -46.34 Thousand | 8575.00 | 76.89 Thousand |
| Other non-cash items | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | 356.29 Thousand | 75.65 Thousand | 21.9 Thousand |
| Debt repayment | - | - | - | -356.29 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | -280.64 Thousand | 21.9 Thousand |
| Other Financing Activities | - | - | - | - | 356.29 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 573.93 Thousand | -55.64 Thousand | 75.09 Thousand | -46.34 Thousand | 8575.00 | 76.89 Thousand |
| Cash at beginning of period | 3603.00 | 3548.00 | 1708.00 | 66.68 Thousand | 29.73 Thousand | - |
| Cash at end of period | 7938.00 | 3603.00 | 3548.00 | 1708.00 | 1708.00 | 29.73 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4335.00 | 55.00 | 1840.00 | -64.97 Thousand | -28.02 Thousand | 29.73 Thousand |
| Free Cash Flow | 4335.00 | 55.00 | 1840.00 | -421.26 Thousand | -103.67 Thousand | 7835.00 |
BZFD
TRTN-PC
2533
9345
EPIGRAL
GOT